List view / Grid view

Mike Filbin (Massachusetts General Hospital)

 

article

Investigating cellular pathways driving severe COVID-19 with proteomics

Researchers from Massachusetts General Hospital have studied several thousand circulating…

27 November 2020 | By

Researchers from Massachusetts General Hospital have studied several thousand circulating proteins within the plasma proteome of symptomatic COVID-19 patients and acutely ill non-COVID-19 controls. Nikki Withers discussed their findings and implications of the study with one of the lead authors, Dr Mike Filbin.

article

COVID-19 In-Depth Focus 2020

This in-depth focus features articles on neuropilin-1, a potential new…

27 November 2020 | By

This in-depth focus features articles on neuropilin-1, a potential new target for COVID-19 drug development, the creation of a lung model to enhance our understanding of SARS-CoV-2 infections and using proteomics to uncover the mechanisms behind COVID-19 symptom severity.